A Modified Progressive Supranuclear Palsy Rating Scale.

Area of Science:

• Neurology
• Clinical Assessment
• Disease Progression

Background:

• The Progressive Supranuclear Palsy Rating Scale (PSPRS) is a physician-rated measure for disease severity.
• Experts questioned the relevance of individual PSPRS items to patient quality of life, daily function, and mortality.
• Changes in the original scale may not reflect clinically meaningful patient status changes.

Purpose of the Study:

• To create a condensed, modified version of the PSPRS focused on significant disease milestones.
• To improve the scale's ability to capture clinically meaningful changes in progressive supranuclear palsy.

Main Methods:

• Movement disorder experts evaluated each item for its capacity to represent disease milestones.
• Items not indicating severe milestones were removed, and remaining items were recalibrated.
• Longitudinal data from 86 patients were used to eliminate items with low sensitivity to change.

Main Results:

• A 14-item modified PSPRS was developed, with items rated for functional relevance to disease milestones.
• The modified scale demonstrated sensitivity to change over 6 and 12 months.
• The modified scale offers comparable statistical power to the original for clinical trials.

Conclusions:

• The modified PSPRS is a clinimetrically sound tool for monitoring disease progression.
• This revised scale can be utilized in both clinical trials and routine patient care.
• The scale provides a more meaningful assessment of progressive supranuclear palsy progression.